Skip to main content

Advertisement

Log in

Immunoglobulin (IgG4) Sclerosing Cholecystitis-Camouflaging Gall Bladder Cancer—a Case Report and Review of Literature

  • Case Report
  • Published:
SN Comprehensive Clinical Medicine Aims and scope Submit manuscript

Abstract

IgG4-related disease is a rare systemic disorder having an underlying autoimmune cause. These disorders mainly affects pancreatico biliary tree, i.e., pancreas, gall bladder, and biliary tree (extrahepatic as well intrahepatic), but can also affect other part of the body. Majority of disorders involving biliary tree are associated with autoimmune pancreatitis component. These disorders are difficult to diagnose clinically as they can mimic inflammatory as well malignancy and poses a real diagnostic challenge to manage and treat. Sixty-four-year-old female known diabetic evaluated for pain in right hypochondrium. Gall bladder cancer was suspected clinically as well on radiological basis. Patient underwent extended cholecystectomy as it was a resectable disease. Final histopathology revealed immunoglobulin G4 (IgG4)-related cholecystitis which was confirmed after immunohistochemistry for CD 138 and IgG4.This disease could be managed conservatively by giving oral steroids, if it has been picked up preoperatively and major surgical intervention have been avoided. No defined blood test or tumor markers are currently available to diagnose this entity except serum immunoglobulin G4 which is costly and not feasible to get done in all patients especially in developing nations like India. IgG4 cholecystitis is an immune-mediated disease whose pathophysiology is still not completely understood. Every clinician should keep possibility of IgG4 cholecystitis in mind whenever any patient with abnormal gall bladder thickening or gall bladder mass is encountered in their clinical practice, as both these entities have completely different options of treatment. We should not rely solely upon clinical and radiological picture.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3

Similar content being viewed by others

Data Availability

Not applicable.

Abbreviations

IgG4 :

Immunoglobulin G4

IgG4-RD :

Immunoglobulin G4-related disorder

References

  1. Kamisawa T, Funata N, Hayashi Y, et al. A new clinicopathological entity of IgG4-related autoimmune disease. J Gastroenterol. 2003;38:982–4.

    Article  CAS  PubMed  Google Scholar 

  2. Kulkarni AA, et al. Immunoglobulin G4-related disease mimicking gallbladder cancer with associated choledochal cyst: a case report of a malignant masquerade. J Gastroenterol Hepatol Open. 2019;3(6):536–9.

    Google Scholar 

  3. Umehara H, et al. The 2020 revised comprehensive diagnostic (RCD) criteria for IgG4-RD. Modern Rheumatol. 2021;31(3):529–33.

    Article  CAS  PubMed  Google Scholar 

  4. Lopes J, Hochwald SN, Lancia N, Dixon LR, Ben-David K. Autoimmune esophagitis: IgG4-related tumors of the esophagus. J Gastrointest Surg. 2010;14:1031–4.

    Article  PubMed  Google Scholar 

  5. Abraham SC, Cruz-Correa M, Argani P, Furth EE, Hruban RH, Boitnott JK. Lymphoplasmacytic chronic cholecystitis and biliary tract disease in patients with lymphoplasmacytic sclerosing pancreatitis. Am J Surg Pathol. 2003;27(4):441–51.

    Article  PubMed  Google Scholar 

  6. Detlefsen S, Drewes AM. Autoimmune pancreatitis. Scand J Gastroenterol. 2009;44(12):1391–407.

    Article  CAS  PubMed  Google Scholar 

  7. Umehara H, Okazaki K, Masaki Y, et al. A novel clinical entity, IgG4-related disease (IgG4RD): general concept and details. Mod Rheumatol. 2012;22:1–14.

    Article  CAS  PubMed  Google Scholar 

  8. Erdogan D, Kloek JJ, ten Kate FJ, et al. Immunoglobulin G4-related sclerosing cholangitis in patients resected for presumed malignant bile duct strictures. Br J Surg. 2008;95:727–34.

    Article  CAS  PubMed  Google Scholar 

  9. Yamamoto M, Takahashi H, Takano K, et al. Response to: ‘Could abatacept directly target expanded plasmablasts in IgG4-related disease?’ Ann Rheum Dis. 2016;75:e74.

    Article  PubMed  Google Scholar 

  10. Kamisawa T, Okamoto A. Autoimmune pancreatitis: proposal of IgG4-related sclerosing disease. J Gastroenterol. 2006;41(7):613–25.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  11. Kurowecki D, Patlas MN, Haider EA, Alabousi A. Cross-sectional pictorial review of IgG4-related disease. Br J Radiol. 2019;92:20190448.

    Article  PubMed  PubMed Central  Google Scholar 

  12. Vlachou PA, Khalili K, Jang HJ, Fischer S, Hirschfield GM, Kim TK. IgG4-related sclerosing disease: autoimmune pancreatitis and extrapancreatic manifestations. Radiographics. 2011;31(5):1379–402.

    Article  PubMed  Google Scholar 

  13. Deshpande V, Zen Y, Chan JK, et al. Consensus statement on the pathology of IgG4-related disease. Mod Pathol. 2012;25:1181–92.

    Article  PubMed  Google Scholar 

  14. Shin SW, Kim Y, Jeong WK, Kim J, Kim MY, Oh YH, Pyo JY. Isolated cholecystitis mimicking gallbladder cancer: a case report. Clin Imaging. 2013;37:969–71.

    Article  PubMed  Google Scholar 

  15. Wang YF, Feng FL, Zhao XH, Ye ZX, Zeng HP, Li Z, Jiang XQ, Peng ZH. Combined detection tumor markers for diagnosis and prognosis of gallbladder cancer. World J Gastroenterol. 2014;20:4085.

    Article  PubMed  PubMed Central  Google Scholar 

  16. Ishigami K, et al. Ectopic relapse of IgG4-related disease presenting as IgG4-related sclerosing cholecystitis-A case report and review of literature. Medicine (Baltimore). 2018;97(52):e13868.

    Article  PubMed  Google Scholar 

  17. Ghazale A, Chari ST, Zhang L, et al. Immunoglobulin G4-associated cholangitis: clinical profile and response to therapy. Gastroenterology. 2008;134:706–15.

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Contributions

RS—drafted the case manuscript and was the main operating surgeon. PM—part of surgical team and helped in drafting the manuscript. RP, VR, JS, CK—all were part of surgical team and helped in citing references for the case report. JG—helped in framing discussion part. KM—reported the final histopathology report. All authors read and approved the final manuscript.

Corresponding author

Correspondence to Rashpal Singh.

Ethics declarations

Ethics Approval and Consent to Participate

Not applicable for this section.

Consent for Publication

Consent for publication has been obtained from the patient in a proper informed consent form.

Conflict of Interest

The authors declare no competing interests.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

This article is part of the Topical Collection on Medicine

Rights and permissions

Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Singh, R., Mahajan, P., Prasher, R. et al. Immunoglobulin (IgG4) Sclerosing Cholecystitis-Camouflaging Gall Bladder Cancer—a Case Report and Review of Literature. SN Compr. Clin. Med. 5, 43 (2023). https://doi.org/10.1007/s42399-022-01371-2

Download citation

  • Accepted:

  • Published:

  • DOI: https://doi.org/10.1007/s42399-022-01371-2

Keywords

Navigation